You can find the annual or quarterly income statement of MDNA Life Sciences Units (Proposed) here for insights into the performance and operational efficiency of MDNA Life Sciences Units (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2023Q1

FY2022Q1

FY2021Q4

Total revenue

--475.00

--1.09M

--1.18M

Revenue

--475.00

--1.09M

--1.18M

Cost of revenue

--40.51K

--484.08K

--600.17K

Operating expenses

--787.15K

--1.44M

--1.46M

R&D expenses

--100.63K

--535.23K

--225.33K

Depreciation, depletion, and amortization

--88.40K

--124.32K

--91.25K

Operating profit

---786.67K

---348.30K

---285.39K

Net non-operating interest income (expenses)

Non-operating interest expense

--805.89K

--1.70M

--418.84K

Gains from sale of securities

---159.92K

--412.03K

---108.27K

Special income (expenses)

--210.22K

---68.47K

----

Income before tax

---1.54M

---1.70M

---812.49K

Income tax

--0.00

Income after tax

---1.54M

---1.70M

---812.49K

Net income from continuous operations

---1.54M

---1.70M

---812.49K

Net income attributable to controlling interests

---1.77M

---1.91M

---1.02M

Preferred share dividend

--223.96K

--206.91K

--202.85K

Net income attributable to common shareholders

---1.77M

---1.91M

---1.02M

Basic earnings per share

---0.19

---0.20

---0.14

Diluted earnings per share

---0.19

---0.20

---0.14

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

